Healthcare - Biotechnology - NASDAQ - AU
$ 1.105
-5.56 %
$ 9.8 M
Market Cap
-0.54
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
--34.43%
EBIT
Estimate
63.45%
Net Income
Estimate
--227.67%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Alterity Therapeutics Limited
ATHE has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart ATHE
EBIT FORECAST
EBIT Forecast Chart ATHE
NET INCOME FORECAST
Net Income Chart ATHE